Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells-Reference-Cited by-同舟云学术

Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells

Published:2020-04-15 Issue:7809 Volume:581 Page:475-479
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Campbell Clarissa,McKenney Peter T.^ORCID,Konstantinovsky Daniel,Isaeva Olga I.,Schizas Michail,Verter Jacob^ORCID,Mai Cheryl,Jin Wen-Bing,Guo Chun-Jun,Violante Sara,Ramos Ruben J.,Cross Justin R.,Kadaveru Krishna,Hambor John,Rudensky Alexander Y.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-020-2193-0.pdf

Reference34 articles.

1. Josefowicz, S. Z. et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482, 395–399 (2012).

2. Zheng, Y. et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808–812 (2010).

3. Nutsch, K. et al. Rapid and efficient generation of regulatory T cells to commensal antigens in the periphery. Cell Rep. 17, 206–220 (2016).

4. Kim, K. S. et al. Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine. Science 351, 858–863 (2016).

5. Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451–455 (2013).

Cited by 513 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cascade catalysis nanozyme for interfacial functionalization in combating implant infections associated with diabetes via sonodynamic therapy and adaptive immune activation;Biomaterials;2024-12

2. The role of intestinal microbiota and metabolites in intestinal inflammation;Microbiological Research;2024-11

3. A comprehensive review on utilizing CRISPR/Cas system for microbiome modification;Biochemical Engineering Journal;2024-11

4. Polysaccharides to postbiotics: Nurturing bone health via modulating “gut-immune axis”;International Journal of Biological Macromolecules;2024-10

5. Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases;Pharmacological Research;2024-10